Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseHow many molecular subtypes? Implications of the unique tumor principle in personalized medicineDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyProgress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Ogino et Al. Respond to "the 21st century epidemiologist".Proceedings of the second international molecular pathological epidemiology (MPE) meetingEstrogen receptors and their implications in colorectal carcinogenesis.Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women.Integration of molecular pathology, epidemiology and social science for global precision medicine.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancerReview Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classificationPrognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour locationAssociations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women.Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology.
P2860
Q24289344-D4C2188A-473E-4054-896D-6FA294D6A768Q26992045-9AF99898-0506-4697-B5E4-0563197CC4E8Q27011884-131F8D7F-7C3F-44A9-AD2E-6EB502658F7EQ34016833-FCFC1907-2AB2-42FC-AF8D-A4A80DE97BAAQ34296789-D48B2BA6-F920-4CCD-9F34-08043F3DA6BEQ34475686-21CB0D75-FEE0-489E-8C15-314EBBAF9FC7Q35037282-E2B19775-8585-477B-BF2A-F7AF233B3948Q35251758-19D67175-C48C-454B-937D-B82900FE506CQ36463854-79C711EB-B8A3-499C-BCD6-16F2241DCCC7Q36675320-1AC307CC-4004-4BB1-8E6F-7A233EEE9C95Q36926941-422D54BB-C91A-47B2-B43B-5411577EC972Q36968401-D07030B3-5D9D-40B5-9FC7-CCFE38EEB45DQ36974863-29D707BD-B2D5-49A9-8B07-9EF12B7C95C3Q37111201-1C3A7B5D-BB3B-4E91-8483-71A81F4661AFQ37607304-EE5B79B4-E620-4BFE-AB84-DAC63C08605DQ47138060-DDCFAD49-CD1B-40E4-BBA4-6105E943F046
P2860
Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Postmenopausal hormone therapy ...... ation status among older women
@ast
Postmenopausal hormone therapy ...... ation status among older women
@en
type
label
Postmenopausal hormone therapy ...... ation status among older women
@ast
Postmenopausal hormone therapy ...... ation status among older women
@en
prefLabel
Postmenopausal hormone therapy ...... ation status among older women
@ast
Postmenopausal hormone therapy ...... ation status among older women
@en
P2093
P2860
P50
P1476
Postmenopausal hormone therapy ...... ation status among older women
@en
P2093
Alice H Wang
Amy J French
Charles F Lynch
David Limsui
Kristin E Anderson
Lisa J Harnack
Lori S Tillmans
Paul J Limburg
Robert W Haile
Stephen N Thibodeau
P2860
P304
P356
10.1158/1055-9965.EPI-11-1168
P577
2012-02-15T00:00:00Z